Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase
- PMID: 15025511
- DOI: 10.1021/tx0342161
Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase
Abstract
The postulated scheme for the metabolism of inorganic As involves alternating steps of oxidative methylation and of reduction of As from the pentavalent to the trivalent oxidation state, producing methylated compounds containing AsIII that are highly reactive and toxic. S-Adenosyl-L-methionine:AsIII methyltransferase purified from rat liver catalyzes production of methyl and dimethyl arsenicals from inorganic As. This protein is encoded by the cyt19 gene orthologous with cyt19 genes in mouse and human. The reductants dithiothreitol or tris(2-carboxylethyl)phosphine support catalysis by recombinant rat cyt19 (rrcyt19). Coupled systems containing an endogenous reductant (thioredoxin/thioredoxin reductase/NADPH, glutaredoxin/glutathione/glutathione reductase/NADPH, or lipoic acid/thioredoxin reductase/NADPH) support inorganic As methylation by rrcyt19. Although glutathione alone does not support rrcyt19's catalytic function, its addition to reaction mixtures containing other reductants increases the rate of As methylation. Aurothioglucose, an inhibitor of thioredoxin reductase, reduces the rate of As methylation by rrcyt19 in thioredoxin-supported reactions. Addition of guinea pig liver cytosol, a poor source of endogenous As methyltransferase activity, to reaction mixtures containing rrcyt19 shows that endogenous reductants in cytosol support the enzyme's activity. Methylated compounds containing either AsIII or AsV are detected in reaction mixtures containing rrcyt19, suggesting that cycling of As between oxidation states is a component of the pathway producing methylated arsenicals. This enzyme may use endogenous reductants to reduce pentavalent arsenicals to trivalency as a prerequisite for utilization as substrates for methylation reactions. Thus, cyt19 appears to possess both AsIII methyltransferase and AsV reductase activities.
Similar articles
-
A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.Arch Toxicol. 2005 Apr;79(4):183-91. doi: 10.1007/s00204-004-0620-x. Epub 2004 Nov 4. Arch Toxicol. 2005. PMID: 15526190
-
Elucidating the pathway for arsenic methylation.Toxicol Appl Pharmacol. 2004 Aug 1;198(3):319-26. doi: 10.1016/j.taap.2003.10.020. Toxicol Appl Pharmacol. 2004. PMID: 15276411
-
Methylation of arsenic by recombinant human wild-type arsenic (+3 oxidation state) methyltransferase and its methionine 287 threonine (M287T) polymorph: Role of glutathione.Toxicol Appl Pharmacol. 2012 Oct 1;264(1):121-30. doi: 10.1016/j.taap.2012.07.024. Epub 2012 Jul 31. Toxicol Appl Pharmacol. 2012. PMID: 22868225 Free PMC article.
-
Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals.Exp Biol Med (Maywood). 2007 Jan;232(1):3-13. Exp Biol Med (Maywood). 2007. PMID: 17202581 Free PMC article. Review.
-
Role of arsenic (+3 oxidation state) methyltransferase in arsenic metabolism and toxicity.Biol Pharm Bull. 2012;35(11):1870-5. doi: 10.1248/bpb.b212015. Biol Pharm Bull. 2012. PMID: 23123458 Review.
Cited by
-
Comparative oxidation state specific analysis of arsenic species by high-performance liquid chromatography-inductively coupled plasma-mass spectrometry and hydride generation-cryotrapping-atomic absorption spectrometry.J Anal At Spectrom. 2013 Jun 1;28(6):843-852. doi: 10.1039/C3JA30380B. J Anal At Spectrom. 2013. PMID: 23687401 Free PMC article.
-
Arsenic detoxification and evolution of trimethylarsine gas by a microbial arsenite S-adenosylmethionine methyltransferase.Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2075-80. doi: 10.1073/pnas.0506836103. Epub 2006 Feb 1. Proc Natl Acad Sci U S A. 2006. PMID: 16452170 Free PMC article.
-
Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues.Metallomics. 2011 Dec;3(12):1347-54. doi: 10.1039/c1mt00095k. Epub 2011 Oct 21. Metallomics. 2011. PMID: 22015847 Free PMC article.
-
Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions.Toxicol Appl Pharmacol. 2009 Sep 1;239(2):200-7. doi: 10.1016/j.taap.2009.06.007. Epub 2009 Jun 16. Toxicol Appl Pharmacol. 2009. PMID: 19538983 Free PMC article.
-
Pathway of human AS3MT arsenic methylation.Chem Res Toxicol. 2014 Nov 17;27(11):1979-89. doi: 10.1021/tx500313k. Epub 2014 Oct 30. Chem Res Toxicol. 2014. PMID: 25325836 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials